Boehringer Ingelheim Pharmaceuticals, Inc. recalls Catapres (clonidine hydrochloride, USP) 0.3 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharm
Recalled November 4, 2020 · FDA recall D-0053-2021 · Boehringer Ingelheim Pharmaceuticals
Hazard
An extraneous peak was observed for dissolution testing. · FDA Class II
Units
N/A
Sold at
Distributed Nationwide in the USA and Puerto Rico
Description
An extraneous peak was observed for dissolution testing.
Product
Catapres (clonidine hydrochloride, USP) 0.3 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877, Made in Germany, NDC, 0597-0011-01
Manufacturer(s)
Boehringer Ingelheim Pharmaceuticals, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →